Showing results (721-730 of 3,472) with videos related to
Sort By:
Pageof 348
Clinical Pharmacokinetics|April 29, 2015
Clinical Pharmacokinetic Studies of EnzalutamideJacqueline A Gibbons, Taoufik Ouatas, Walter Krauwinkel, et al.Clinical Pharmacokinetics|May 6, 2015
Prediction of Fat-Free Mass in ChildrenHesham Saleh Al-Sallami, Ailsa Goulding, Andrea Grant, et al.Clinical Pharmacokinetics|January 1, 1977
Protein binding and kinetics of drugs in liver diseasesT F BlaschkeClinical Pharmacokinetics|May 1, 1983
Pharmacokinetics of phenylethylmalonamide (PEMA) after oral and intravenous administrationF Pisani, A RichensClinical Pharmacokinetics|March 1, 1982
Patient-controlled analgesic therapy. Part I: Pharmacokinetics of pethidine in the per- and postoperative periodsA Tamsen, P Hartvig, C Fagerlund, et al.Clinical Pharmacokinetics|March 1, 1982
Patient-controlled analgesic therapy, Part II: Individual analgesic demand and analgesic plasma concentrations of pethidine in postoperative painA Tamsen, P Hartvig, C Fagerlund, et al.Clinical Pharmacokinetics|July 1, 1982
Time-course of transplacental passage of diazepam: Influence of injection-delivery interval on neonatal drug concentrationsO M Bakke, K HaramClinical Pharmacokinetics|March 1, 1981
The effect of malnutrition on the pharmacokinetics of phenylbutazoneK Krishnaswamy, V Ushasri, N A NaiduClinical Pharmacokinetics|February 2, 2023
Evaluation of the Influence of Sildenafil on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vericiguat in Healthy AdultsMichael Boettcher, Bettina Nowotny, Robert Krausche, et al.Clinical Pharmacokinetics|February 17, 2023
Justifying Ribociclib Dose in Patients with Advanced Breast Cancer with Renal Impairment Based on PK, Safety, and Efficacy Data: An Innovative Approach Integrating Data from a Dedicated Renal Impairment Study and Oncology Clinical TrialsYan Ji, Vitaly Yartsev, Michelle Quinlan, et al.Pageof 348